Literature DB >> 17936884

Antagonism of phencyclidine-induced stimulus control in the rat by other psychoactive drugs.

J C Winter1.   

Abstract

It has been observed that agents with agonist activity at 5-HT2A receptors prevent neurotoxicity induced by the non-competitive NMDA antagonist, dizocilpine (MK-801). Subsequent behavioral studies reported complete antagonism by LSD and DOM of the stimulus effects of the related NMDA antagonist, phencyclidine [PCP]. The present study sought to extend those observations to include other psychoactive drugs. Male F-344 rats were trained in a 2-lever, fixed-ratio 10, food-reinforced task with PCP (3.0 mg/kg; IP; 30 min pretreatment) as a discriminative stimulus. Tests of generalization were then conducted using the training dose of PCP in combination with a range of doses of DOM, LSD, d-amphetamine, MDMA, psilocybin, buspirone, and GHB. All of the drugs tested in combination with PCP produced a statistically significant diminution of PCP-appropriate responding but for none was antagonism complete. These data, obtained using a stimulus control model of the hallucinogenic effects of PCP, fail to support the hypothesis that LSD and DOM completely antagonize stimulus control by PCP. Instead, the data suggest complex interactions between PCP-induced stimulus control and a variety of psychoactive drugs including GHB, an agent with no known affinity for serotonergic receptors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17936884      PMCID: PMC2322868          DOI: 10.1016/j.pbb.2007.07.007

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  60 in total

1.  STATE-DEPENDENT OR "DISSOCIATED" LEARNING PRODUCED WITH PENTOBARBITAL.

Authors:  D A OVERTON
Journal:  J Comp Physiol Psychol       Date:  1964-02

Review 2.  Gamma-hydroxybutyric acid.

Authors:  O Carter Snead; K Michael Gibson
Journal:  N Engl J Med       Date:  2005-06-30       Impact factor: 91.245

3.  Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat.

Authors:  Daniel Klamer; Jianhua Zhang; Jörgen A Engel; Lennart Svensson
Journal:  Behav Brain Res       Date:  2005-04-15       Impact factor: 3.332

Review 4.  Hallucinogens as discriminative stimuli.

Authors:  J C Winter
Journal:  Fed Proc       Date:  1974-07

5.  Discriminative stimulus effects of flumazenil: perceptual masking by baclofen, and lack of substitution with gamma-hydroxybutyrate and its precursors 1,4-butanediol and gamma-butyrolactone.

Authors:  Wouter Koek; Lawrence P Carter; Huifang Wu; Andrew Coop; Charles P France
Journal:  Behav Pharmacol       Date:  2006-05       Impact factor: 2.293

6.  Serotonergic/glutamatergic interactions: potentiation of phencyclidine-induced stimulus control by citalopram.

Authors:  J C Winter; J R Eckler; K C Rice; R A Rabin
Journal:  Pharmacol Biochem Behav       Date:  2005-07       Impact factor: 3.533

7.  Attenuation of nicotine's discriminative stimulus effects in rats and its locomotor activity effects in mice by serotonergic 5-HT2A/2C receptor agonists.

Authors:  Angela M Batman; Patrik Munzar; Patrick M Beardsley
Journal:  Psychopharmacology (Berl)       Date:  2004-11-25       Impact factor: 4.530

8.  Topiramate antagonizes MK-801 in an animal model of schizophrenia.

Authors:  Stephen I Deutsch; Richard B Rosse; Eddie N Billingslea; Alan S Bellack; John Mastropaolo
Journal:  Eur J Pharmacol       Date:  2002-08-02       Impact factor: 4.432

9.  Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats.

Authors:  W E Fantegrossi; A W Harrington; C L Kiessel; J R Eckler; R A Rabin; J C Winter; A Coop; K C Rice; J H Woods
Journal:  Pharmacol Biochem Behav       Date:  2006-02-03       Impact factor: 3.533

10.  Serotonin 5-HT1A receptors regulate NMDA receptor channels through a microtubule-dependent mechanism.

Authors:  Eunice Y Yuen; Qian Jiang; Paul Chen; Zhenglin Gu; Jian Feng; Zhen Yan
Journal:  J Neurosci       Date:  2005-06-08       Impact factor: 6.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.